AI assistant
Axogen, Inc. — Director's Dealing 2025
Feb 26, 2025
32414_dirs_2025-02-26_dc4be22d-f012-4df8-9b11-ece26efdf42f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Axogen, Inc. (AXGN)
CIK: 0000805928
Period of Report: 2025-02-22
Reporting Person: Kemp Jens (Chief Marketing Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-02-22 | Common Stock | M | 2500 | — | Acquired | 2500 | Direct |
| 2025-02-25 | Common Stock | F | 814 | $16.49 | Disposed | 1686 | Direct |
Footnotes
F1: This reflects the number of shares issued upon the attainment of certain performance criteria.
F2: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of performance stock units ("PSUs") on February 22, 2025. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.
F3: The reported price in Column 4 is a weighted average sale price. These shares were sold on February 25, 2025 in multiple transactions at prices ranging from $16.42 to $17.32 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.